News

Imagine an interview with these 2 talking entities…

From addressing physician burnout to helping your patients incorporate friendships into their lives, here are highlights from the week in Psychiatric Times.

Seems like a reasonable assessment...

“Maybe Black History Month should be more centered around the contributions of Black Americans—what they have contributed to what this country is. I would love to know more about that.”

"By year’s end, brittle with guilt, we hovered over our hollow creation..."

Names can hurt, and they can lead to broken bones.

Could police brutality be part of a larger legacy of American trauma transmission?

The 2022 Sigourney Award winner reflects on her work.

“Anyone who cares about patients is doomed to burnout.”

In honor of Black History Month, Psychiatric Times™ highlights the contributions of Black clinicians to the field of psychiatry, as well as issues that continue to impact this underrepresented community.

The experts weighed in on a wide variety of psychiatric issues for the January 2023 issue of Psychiatric Times.

“Bringing us home, To ourselves, Our selves, Our bodies, our shelters…”

Should we try to be the keepers of our brothers and sisters?

How can you get involved and be more knowledgeable about social psychiatry?

A psychiatric reflects on the latest news and remembers Tyre Nichols.

From special issues in diagnosing and treating catatonia to helping justice-involved individuals re-enter the community, here are highlights from the week in Psychiatric Times.

No good deed goes unpunished...

The agency’s conclusions are based on regulatory oversight needed to manage risks associated with CBD and other cannabis-derived products.

Be on the lookout for anti-Semitic messages.

In remembrance of those we lost…

SPL026 with supportive therapy sees positive results in patients with major depressive disorder.

How can recovery-oriented cognitive therapy be a game changer for these individuals?

“We are oceans, not boats.”

Back to the future… or blast to the past?

Are you ready to understand how recovery-oriented cognitive therapy (CT-R) promotes wellness and empowerment for individuals experiencing serious mental health challenges? Check out this CME article.

Catatonia: learn more about how to best diagnose early.

This morning, we mourn the victims of the Monterey Park mass shooting.

From a new FDA approval to treating “New Year depression” in patients, here are highlights from the week in Psychiatric Times.

The FDA has accepted the NDA for nasal nalmefene, OPNT003, to treat opioid overdose.